State of the Union 2026: State‐Level Updates and National Trends in Pharmacist Payment Reform

State-level progress toward pharmacist reimbursement continues to expand, prompting the need for periodic updates to prior reviews. The 2024 State of the Union manuscript acknowledged that state laws and Medicaid policies governing pharmacist payment evolve rapidly and would require regular reassessment to maintain accuracy and relevance. This 2026 update responds to that limitation by highlighting new legislative, regulatory, and Medicaid coverage developments enacted since April 2024, refining comparisons across commercial and Medicaid pathways, and providing analysis of emerging trends in pharmacist reimbursement. Since the prior review, substantial changes have occurred in Alaska, Connecticut, Delaware, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, North Carolina, Oregon, and Utah. These updates include expansion of pharmacist test-and-treat authority, new commercial coverage mandates, explicit Medicaid provider enrollment and reimbursement structures, and broadened scope-of-practice provisions tied to payment. While legislative mandates remain a primary vehicle for reform, durable integration of pharmacist services depends on payer infrastructure alignment, health system implementation capacity, and connection to performance-based quality metrics. Collectively, these developments reinforce the emergent bottom-up trajectory of pharmacist reimbursement reform and highlight the steady, incremental strengthening of pharmacist integration within state health systems.